Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2017 | R44 | CA188154 | PAR-13-327 | PREMSRIRUT, PREM KHOVABUTR | MIRIMUS, INC. | Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research | Complete |
2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
2010 | R44 | CA140047 | RFA-CA-08-011 | CHEN, WEN-TIEN | VITATEX, INC. | CANCER PROGENIYOR CELL MARKERS | Complete |
2003 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
2013 | R44 | CA133987 | RFA-CA-08-011 | DUFFY, DAVID C | QUANTERIX CORPORATION | SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS | Complete |
2003 | R44 | CA099333 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER | Complete |
2020 | R44 | CA250672 | PAR-18-303 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC. | Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform | Complete |
2003 | R44 | CA083390 | PAR-01-105 | WIKTOR, PETER J. | ENGINEERING ARTS | PIEZOELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS | Complete |
2002 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
2003 | R44 | CA094400 | PAR-99-101 | GAO, JUN | CALIBRANT BIOSYSTEMS, INC. | ELECTRONIC PROTEIN TRANSFER FOR PROTEOME ANALYSIS | Complete |
2002 | R44 | CA094419 | PAR-99-101 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | LIGHT-UP PNA ARRAYS | Complete |
2000 | R44 | CA088684 | PAR-99-101 | LEVENSON, RICHARD M. | CAMBRIDGE RESEARCH AND INSTRUMENTATION | SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM | Complete |
2002 | R44 | CA081835 | PAR-01-105 | DREES, BETH E | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |
2000 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
2002 | R44 | CA088396 | PAR-01-105 | MOEN, PHILLIP T | ONE CELL SYSTEMS, INC | DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS | Complete |
2000 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
1999 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
2005 | R44 | CA101106 | RFA-CA-05-006 | RUSH, JOHN | CELL SIGNALING TECHNOLOGY, INC. | IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES | Complete |
1999 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
2005 | R44 | CA107988 | PAR-01-105 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS | Complete |
2008 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2008 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2006 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2006 | R44 | CA121155 | RFA-CA-06-005 | LU, PETER S. | ARBOR VITA CORPORATION | A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Complete |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2023 | R61 | CA278398 | RFA-CA-22-001 | GAO, XIAOJING J | STANFORD UNIVERSITY | Program the Immune System against RAS-driven Cancer | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2023 | R61 | CA281795 | RFA-CA-22-001 | CAMPAGNOLA, PAUL J | UNIVERSITY OF WISCONSIN-MADISON | A novel multimodal ECM analysis platform for tumor characterization combining morphological and spectrochemical tissue imaging approaches. | Active |
2023 | R61 | CA281807 | RFA-CA-22-001 | HACOHEN, NIR | BROAD INSTITUTE, INC. | Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries | Active |
2023 | R61 | CA278558 | RFA-CA-22-001 | YAN, HAO | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | High-throughput, purification-free, and ultrasensitive transmembrane nanosensor arrays for digital counting of microRNA biomarkers of intact exosomes | Active |
2023 | R61 | CA281657 | RFA-CA-22-001 | LUKER, GARY D | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Integrated Imaging Tools for Intercellular Chemokine Signalling | Active |
2023 | R61 | CA278402 | RFA-CA-22-001 | BRAVO CORDERO, JOSE JAVIER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | Intersectional genetics-based biosensors for dormant cancer cells | Active |
2023 | R61 | CA278531 | RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood | Active |
2006 | U43 | CA122745 | RFA-CA-06-006 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES | Complete |